Metro Minnesota Community Oncology Research Consortium (Mmcorc)

Saint Paul, Minnesota 55101-2502

1 studies enrolling now · 2 studies all time

What they study most

HR+/HER2- Breast Cancer, NSCLC, Non-small Cell Lung Cancer

Studies at this site

• BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease — Recruiting now
• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early